Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
16.7M
-
Shares change
-
+642K
-
Total reported value, excl. options
-
$407M
-
Value change
-
+$14.9M
-
Number of buys
-
48
-
Number of sells
-
-28
-
Price
-
$24.37
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2020
82 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q4 2020.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.7M shares
of 148M outstanding shares and own 11.27% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.74M shares), ORBIMED ADVISORS LLC (3.73M shares), WELLINGTON MANAGEMENT GROUP LLP (1.26M shares), EVENTIDE ASSET MANAGEMENT, LLC (869K shares), FRANKLIN RESOURCES INC (686K shares), BlackRock Inc. (659K shares), CITADEL ADVISORS LLC (490K shares), FMR LLC (454K shares), MORGAN STANLEY (437K shares), and Acuta Capital Partners, LLC (434K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.